Synerkine Pharma announces Series A extension

Written by Theo Dinklo

Synerkine Pharma B.V. announced today that it has added EUR 3.5 million to its Series A funding. The extension was led by Flerie Invest, with support from existing investors Thuja Capital and Utrecht Holdings. Read more…

Theo Dinklo
Previous

Emilie Rodrigues joins Synerkine Pharma
Next

Synerkine collaboration partner receives LSH-TKI grant